DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis-Reference-Cited by-同舟云学术

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Published:2018-11 Issue:11 Volume:19 Page:1459-1467
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Henricks Linda M,Lunenburg Carin A T C,de Man Femke M,Meulendijks Didier,Frederix Geert W J,Kienhuis Emma,Creemers Geert-Jan,Baars Arnold,Dezentjé Vincent O,Imholz Alexander L T,Jeurissen Frank J F,Portielje Johanna E A,Jansen Rob L H,Hamberg Paul,ten Tije Albert J,Droogendijk Helga J,Koopman Miriam,Nieboer Peter,van de Poel Marlène H W,Mandigers Caroline M P W,Rosing Hilde,Beijnen Jos H,Werkhoven Erik van,van Kuilenburg André B P,van Schaik Ron H N,Mathijssen Ron H J,Swen Jesse J,Gelderblom Hans,Cats Annemieke,Guchelaar Henk-Jan,Schellens Jan H M

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. Safety of capecitabine: a review;Mikhail;Expert Opin Drug Saf,2010

2. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors;Lévy;J Clin Oncol,1998

3. Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity;Froehlich;Int J Cancer,2015

4. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001

5. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study;Van Cutsem;J Clin Oncol,2001

Cited by 284 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping;Journal of Pharmaceutical and Biomedical Analysis;2024-10

2. How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry;Biological Psychiatry;2024-10

3. Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review;Therapeutic Drug Monitoring;2024-09-11

4. Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD;Genome Medicine;2024-08-15

5. Reply to: “Is uracil enough for effective pre-emptive DPD testing?”;Clinical Chemistry and Laboratory Medicine (CCLM);2024-08-15